Aker Biomarine ASA
OSE:AKBM
Aker Biomarine ASA
Cash from Operating Activities
Aker Biomarine ASA
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
A
|
Aker Biomarine ASA
OSE:AKBM
|
Cash from Operating Activities
$12.2m
|
CAGR 3-Years
156%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
![]() |
Orkla ASA
OSE:ORK
|
Cash from Operating Activities
kr7.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
![]() |
Leroy Seafood Group ASA
OSE:LSG
|
Cash from Operating Activities
kr2B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
3%
|
|
![]() |
SalMar ASA
OSE:SALM
|
Cash from Operating Activities
kr5.4B
|
CAGR 3-Years
23%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
![]() |
Austevoll Seafood ASA
OSE:AUSS
|
Cash from Operating Activities
kr2.9B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
5%
|
|
![]() |
Mowi ASA
OSE:MOWI
|
Cash from Operating Activities
€916.6m
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
Aker Biomarine ASA
Glance View
Aker BioMarine AS operates as a biotech innovator and Antarctic krill-harvesting company which develops krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company is headquartered in Lysaker, Akershus. The company went IPO on 2020-07-06. The company consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarine’s focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.
See Also
What is Aker Biomarine ASA's Cash from Operating Activities?
Cash from Operating Activities
12.2m
USD
Based on the financial report for Dec 31, 2024, Aker Biomarine ASA's Cash from Operating Activities amounts to 12.2m USD.
What is Aker Biomarine ASA's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
0%
Over the last year, the Cash from Operating Activities growth was -74%. The average annual Cash from Operating Activities growth rates for Aker Biomarine ASA have been 156% over the past three years .